| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease |  | | 2023 | 328 | 234 |
|
| Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells | Communications Biology | | | 2021 | 349 | 232 |
|
| Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients | Neuro-Oncology | | | 2019 | 857 | 844 |
|
